STAT July 30, 2024
In a year marked by European Parliament elections and setting of the European Union’s priorities for the next five years, it’s time for the EU to make innovation in health and biopharmaceuticals a strategic priority for the region’s resilience and security.
Europe is currently facing a competitiveness crisis. EU productivity has declined 1.2% in the fourth quarter of 2023 compared to the previous year, while U.S. productivity rose 2.6%. As France’s President Emmanuel Macron and Germany’s Chancellor Olaf Scholz wrote recently in the Financial Times, “Europe is experiencing its Zeitenwende” (change of era) and must rise to the challenge.
Europe can build on biopharmaceuticals as one of its critical technology sectors, but the time for action is now. Twenty-five years...
Today's Sponsors
Today's Sponsor